article thumbnail

Florida doctors' board tightens ban on gender-affirming care

Medical Xpress

A prohibition against puberty blocking hormones and gender-affirming surgeries for minors in Florida was tightened further after a board overseeing doctors eliminated an exception for clinical trials Friday at the request of Florida Gov. Ron DeSantis' administration.

Doctors 96
article thumbnail

Hormonal therapy won't prevent chronic ills after menopause: Expert panel

Medical Xpress

Experts are once again advising doctors and women against using menopausal hormone therapy to ward off chronic diseases—20 years after a landmark trial dashed those hopes.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Hormone Therapy for Prostate Cancer May Raise Heart Risks

The Pharma Data

20, 2020 — Hormone therapy can be a lifesaver for men with prostate cancer , but it also appears to put some at increased risk of heart problems, a new study reports. Prostate cancer is fueled by male hormones, which are called androgens. But questions have arisen about the effects of long-term hormone therapy on heart health.

article thumbnail

Unblock My Hormones And Start Burning Fat TODAY With HB5

The Pharma Data

Product Name: Unblock My Hormones And Start Burning Fat TODAY With HB5. Click here to get Unblock My Hormones And Start Burning Fat TODAY With HB5 at discounted price while it’s still available… All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors.

article thumbnail

A treatment for a deadly condition in newborns fails to improve outcomes, study finds

STAT News

For babies born with hypoxic-ischemic encephalopathy, commonly called birth asphyxia, doctors have limited options. A new study , published Wednesday in the New England Journal of Medicine, found that the hormone erythropoietin did not improve survival and other outcomes in newborns with hypoxic-ischemic encephalopathy.

article thumbnail

STAT+: Pharmalittle: Merck ends late-stage trial for Keytruda in prostate cancer; doctor group says 60 Minutes segment on Wegovy was an ad

STAT News

The drug was being tested in combination with androgen deprivation therapy and Xtandi in patients with hormone-sensitive prostate cancer that has spread to other parts of the body.  The interim analysis showed the therapy did not extend survival or help extend the time a patient lives without the disease worsening.

Trials 98
article thumbnail

Measuring endocrine disruptors in wastewater

Scienmag

Endocrine disruptors are chemicals that alter the hormonal systems and the development of organisms that are exposed to them, even in small quantities. Doctoral student Julie Robitaille and Professor Valérie Langlois of the Institut national de la recherche scientifique (INRS) are […].